Indeed, a TGFβ-activated stroma is a prominent feature of CMS4 xenografts, wherein elevated stromal TGFβ levels discourage T-cell infiltration, enabling tumours to evade the host immune response [237]. The gene discussed is TGFB1; the disease is neoplasm.